CASI - CASI Pharmaceuticals GAAP EPS of -$0.71 revenue of $3.4M
2024-05-14 10:43:26 ET
More on CASI Pharmaceuticals
- CASI stock rises on positive interim data from early stage trial for its NHL treatment in China
- Seeking Alpha’s Quant Rating on CASI Pharmaceuticals
- Historical earnings data for CASI Pharmaceuticals
- Financial information for CASI Pharmaceuticals